Table of Contents Author Guidelines Submit a Manuscript
Journal of Nucleic Acids
Volume 2011, Article ID 184735, 8 pages
http://dx.doi.org/10.4061/2011/184735
Research Article

Novel Indolocarbazole Derivative 12-(α-L-arabinopyranosyl)indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7-dione Is a Preferred c-Myc Guanine Quadruplex Ligand

1Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 32 Vavilov Street, Moscow 119991, Russia
2Moscow Institute of Physics and Technology, 9 Institutskii per., Dolgoprudny 141700, Russia
3Blokhin Cancer Center, 24 Kashirskoye shosse, Moscow 115478, Russia

Received 26 November 2010; Accepted 4 March 2011

Academic Editor: Luis A. Marky

Copyright © 2011 Dmitry N. Kaluzhny et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Qin and L. H. Hurley, “Structures, folding patterns, and functions of intramolecular DNA G-quadruplexes found in eukaryotic promoter regions,” Biochimie, vol. 90, no. 8, pp. 1149–1171, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. C. E. Nesbit, J. M. Tersak, and E. V. Prochownik, “MYC oncogenes and human neoplastic disease,” Oncogene, vol. 18, no. 19, pp. 3004–3016, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. S. J. Berberich and E. H. Postel, “PuF/NM23-H2/NDPK-B transactivates a human c-myc promoter-CAT gene via a functional nuclease hypersensitive element,” Oncogene, vol. 10, no. 12, pp. 2343–2347, 1995. View at Google Scholar · View at Scopus
  4. T. L. Davis, A. B. Firulli, and A. J. Kinniburgh, “Ribonucleoprotein and protein factors bind to an H-DNA-forming c-myc DNA element: possible regulators of the c-myc gene,” Proceedings of the National Academy of Sciences of the United States of America, vol. 86, no. 24, pp. 9682–9686, 1989. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Simonsson, P. Pecinka, and M. Kubista, “DNA tetraplex formation in the control region of c-myc,” Nucleic Acids Research, vol. 26, no. 5, pp. 1167–1172, 1998. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Seenisamy, E. M. Rezler, T. J. Powell et al., “The dynamic character of the G-quadruplex element in the c-MYC promoter and modification by TMPyP4,” Journal of the American Chemical Society, vol. 126, no. 28, pp. 8702–8709, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Ambrus, D. Chen, J. Dai, R. A. Jones, and D. Yang, “Solution structure of the biologically relevant G-quadruplex element in the human c-MYC promoter. Implications for G-quadruplex stabilization,” Biochemistry, vol. 44, no. 6, pp. 2048–2058, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Balasubramanian and S. Neidle, “G-quadruplex nucleic acids as therapeutic targets,” Current Opinion in Chemical Biology, vol. 13, no. 3, pp. 345–353, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. J. L. Huppert, “Hunting G-quadruplexes,” Biochimie, vol. 90, no. 8, pp. 1140–1148, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Melko and B. Bardoni, “The role of G-quadruplex in RNA metabolism: involvement of FMRP and FMR2P,” Biochimie, vol. 92, pp. 919–926, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Neidle, “Human telomeric G-quadruplex: the current status of telomeric G-quadruplexes as therapeutic targets in human cancer,” FEBS Journal, vol. 277, no. 5, pp. 1118–1125, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Lemarteleur, D. Gomez, R. Paterski, E. Mandine, P. Mailliet, and J. F. Riou, “Stabilization of the c-myc gene promoter quadruplex by specific ligands' inhibitors of telomerase,” Biochemical and Biophysical Research Communications, vol. 323, no. 3, pp. 802–808, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Drygin, A. Siddiqui-Jain, S. O'Brien et al., “Anticancer activity of CX-3543: a direct inhibitor of rRNA biogenesis,” Cancer Research, vol. 69, no. 19, pp. 7653–7661, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Bejugam, S. Sewitz, P. S. Shirude, R. Rodriguez, R. Shahid, and S. Balasubramanian, “Trisubstituted isoalloxazines as a new class of G-quadruplex binding ligands: small molecule regulation of c-kit oncogene expression,” Journal of the American Chemical Society, vol. 129, no. 43, pp. 12926–12927, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. J. A. Salas and C. Méndez, “Indolocarbazole antitumour compounds by combinatorial biosynthesis,” Current Opinion in Chemical Biology, vol. 13, no. 2, pp. 152–160, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Prudhomme, “Biological targets of antitumor indolocarbazoles bearing a sugar moiety,” Current Medicinal Chemistry—Anti-Cancer Agents, vol. 4, no. 6, pp. 509–521, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Nakano and S. Omura, “Chemical biology of natural indolocarbazole products: 30 years since the discovery of staurosporine,” Journal of Antibiotics, vol. 62, no. 1, pp. 17–26, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Ren, C. Bailly, and J. B. Chaires, “NB-506, an indolocarbazole topoisomerase I inhibitor, binds preferentially to triplex DNA,” FEBS Letters, vol. 470, no. 3, pp. 355–359, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Bailly, X. Qu, F. Anizon, M. Prudhomme, J. F. Riou, and J. B. Chaires, “Enhanced binding to DNA and topoisomerase I inhibition by an analog of the antitumor antibiotic rebeccamycin containing an amino sugar residue,” Molecular Pharmacology, vol. 55, no. 2, pp. 377–385, 1999. View at Google Scholar · View at Scopus
  20. C. Bailly, X. Qu, D. E. Graves, M. Prudhomme, and J. B. Chaires, “Calories from carbohydrates: energetic contribution of the carbohydrate moiety of rebeccamycin to DNA binding and the effect of its orientation on topoisomerase I inhibition,” Chemistry and Biology, vol. 6, no. 5, pp. 277–286, 1999. View at Publisher · View at Google Scholar · View at Scopus
  21. D. N. Kalyuzhnyi, V. V. Tatarsk Jr., F. S. Bondarev et al., “Interaction with DNA as a cytotoxicity factor of a novel glycoside derivative of indolocarbazole,” Doklady Biochemistry and Biophysics, vol. 411, no. 1, pp. 365–368, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. D. N. Kaluzhny, V. V. Tatarskiy Jr., L. G. Dezhenkova et al., “Novel antitumor L-arabinose derivative of indolocarbazole with high affinity to DNA,” ChemMedChem, vol. 4, no. 10, pp. 1641–1648, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. J. B. Lepecq and C. Paoletti, “A fluorescent complex between ethidium bromide and nucleic acids. physical-chemical characterization,” Journal of Molecular Biology, vol. 27, no. 1, pp. 87–106, 1967. View at Google Scholar · View at Scopus
  24. A. A. Shtil, S. Mandlekar, R. Yu et al., “Differential regulation of mitogen-activated protein kinases by microtubule-binding agents in human breast cancer cells,” Oncogene, vol. 18, no. 2, pp. 377–384, 1999. View at Publisher · View at Google Scholar · View at Scopus
  25. D. J. Patel, A. T. Phan, and V. Kuryavyi, “Human telomere, oncogenic promoter and 5′-UTR G-quadruplexes: diverse higher order DNA and RNA targets for cancer therapeutics,” Nucleic Acids Research, vol. 35, no. 22, pp. 7429–7455, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. D. Suh and J. B. Chaires, “Criteria for the mode of binding of DNA binding agents,” Bioorganic and Medicinal Chemistry, vol. 3, no. 6, pp. 723–728, 1995. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Seenisamy, S. Bashyam, V. Gokhale et al., “Design and synthesis of an expanded porphyrin that has selectivity for the c-MYC G-quadruplex structure,” Journal of the American Chemical Society, vol. 127, no. 9, pp. 2944–2959, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Arora and S. Maiti, “Effect of loop orientation on quadruplex-TMPyP4 interaction,” Journal of Physical Chemistry B, vol. 112, no. 27, pp. 8151–8159, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. T. P. Garner, H. E. L. Williams, K. I. Gluszyk et al., “Selectivity of small molecule ligands for parallel and anti-parallel DNA G-quadruplex structures,” Organic and Biomolecular Chemistry, vol. 7, no. 20, pp. 4194–4200, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. V. Gonzalez and L. H. Hurley, “The c-MYC NHE III: function and regulation,” Annual Review of Pharmacology and Toxicology, vol. 50, pp. 111–129, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Fry, “Tetraplex DNA and its interacting proteins,” Frontiers in Bioscience, vol. 12, pp. 4336–4351, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. T. A. Brooks and L. H. Hurley, “The role of supercoiling in transcriptional control of MYC and its importance in molecular therapeutics,” Nature Reviews Cancer, vol. 9, no. 12, pp. 849–861, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Gunaratnam, S. Swank, S. M. Haider et al., “Targeting human gastrointestinal stromal tumor cells with a quadruplex-binding small molecule,” Journal of Medicinal Chemistry, vol. 52, no. 12, pp. 3774–3783, 2009. View at Publisher · View at Google Scholar · View at Scopus